Why women choose compounded bioidentical hormone therapy: lessons from a qualitative study of menopausal decision-making
Background: In recent years, compounded bioidentical hormone therapy (CBHT) has emerged as a popular alternative to manufactured, FDA approved hormone therapy (HT)-despite concerns within the medical community and the availability of new FDA approved "bioidentical" products. This study aim...
| Main Authors: | , , |
|---|---|
| Other Authors: | |
| Language: | en |
| Published: |
BIOMED CENTRAL LTD
2017
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10150/626039 http://arizona.openrepository.com/arizona/handle/10150/626039 |